DE60042735D1 - Behandlung von lfa-1 assozieerten krankheiten durch gesteigerte dosen von lfa-1 antagonist - Google Patents
Behandlung von lfa-1 assozieerten krankheiten durch gesteigerte dosen von lfa-1 antagonistInfo
- Publication number
- DE60042735D1 DE60042735D1 DE60042735T DE60042735T DE60042735D1 DE 60042735 D1 DE60042735 D1 DE 60042735D1 DE 60042735 T DE60042735 T DE 60042735T DE 60042735 T DE60042735 T DE 60042735T DE 60042735 D1 DE60042735 D1 DE 60042735D1
- Authority
- DE
- Germany
- Prior art keywords
- lfa
- dose
- antagonist
- treatment
- associated diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12535199P | 1999-03-19 | 1999-03-19 | |
US27304399A | 1999-03-19 | 1999-03-19 | |
US12522899P | 1999-03-19 | 1999-03-19 | |
PCT/US2000/007189 WO2000056363A1 (en) | 1999-03-19 | 2000-03-17 | Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60042735D1 true DE60042735D1 (de) | 2009-09-24 |
Family
ID=27383217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60042735T Expired - Lifetime DE60042735D1 (de) | 1999-03-19 | 2000-03-17 | Behandlung von lfa-1 assozieerten krankheiten durch gesteigerte dosen von lfa-1 antagonist |
Country Status (11)
Country | Link |
---|---|
US (1) | US6652855B1 (de) |
EP (2) | EP1854480A3 (de) |
JP (1) | JP2002540078A (de) |
AT (1) | ATE439145T1 (de) |
AU (1) | AU764382B2 (de) |
CA (1) | CA2367025A1 (de) |
DE (1) | DE60042735D1 (de) |
DK (1) | DK1163003T3 (de) |
ES (1) | ES2331643T3 (de) |
IL (2) | IL145480A0 (de) |
WO (1) | WO2000056363A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1874821T3 (pl) * | 2005-04-26 | 2013-09-30 | Trion Pharma Gmbh | Kombinacja przeciwciał i glikokortykoidów do leczenia raka |
MX2010007393A (es) * | 2008-01-03 | 2010-11-09 | Abbott Biotech Ltd | Anticipacion de eficacia a largo plazo de un compuesto en el tratamiento de psoriasis. |
JP2012254994A (ja) * | 2012-07-23 | 2012-12-27 | Trion Pharma Gmbh | 癌治療のための抗体およびグルココルチコイドの組み合わせ |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT8121814V0 (it) | 1981-05-19 | 1981-05-19 | Nordica Spa | Struttura di scarpetta interna particolarmente per scarponi da sci. |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
WO1988006592A1 (en) | 1987-02-26 | 1988-09-07 | Dana-Farber Cancer Institute, Inc. | Cloning of lfa-1 |
ATE128727T1 (de) | 1987-05-04 | 1995-10-15 | Dana Farber Cancer Inst Inc | Interzellulare adhäsions-moleküle und deren bindungsliganden. |
US5336603A (en) | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
US5002869A (en) | 1987-11-02 | 1991-03-26 | Dana-Farber Cancer Institute | Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes |
US5071964A (en) | 1988-05-04 | 1991-12-10 | Dana-Farber Cancer Institute, Inc. | Protein micelles |
US5147637A (en) | 1988-06-07 | 1992-09-15 | The Rockefeller University | Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma |
CA2008368C (en) | 1989-01-24 | 2003-04-08 | Jeffrey Greve | Soluble molecule related to but distinct from icam-1 |
NO900155L (no) | 1989-01-24 | 1990-07-25 | Molecular Therapeutics Inc | Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1. |
US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5098833A (en) | 1989-02-23 | 1992-03-24 | Genentech, Inc. | DNA sequence encoding a functional domain of a lymphocyte homing receptor |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
WO1990010652A1 (en) | 1989-03-09 | 1990-09-20 | Dana Farber Cancer Institute | Method of treating viral infections using lfa-1 |
ES2097747T3 (es) | 1989-03-09 | 1997-04-16 | Blood Res Center | Molecula de adhesion intercelular 2 y sus ligandos de union. |
WO1990015076A2 (en) | 1989-06-02 | 1990-12-13 | The Johns Hopkins University School Of Medicine | MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
GB9009548D0 (en) | 1990-04-27 | 1990-06-20 | Celltech Ltd | Chimeric antibody and method |
GB9009549D0 (en) | 1990-04-27 | 1990-06-20 | Celltech Ltd | Recombinant antibody and method |
WO1991018011A1 (en) | 1990-05-15 | 1991-11-28 | Swinburne Limited | Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
WO1994002175A1 (en) * | 1992-07-16 | 1994-02-03 | Icos Corporation | Alleviation of symptoms associated with inflammatory disease states |
ES2112431T3 (es) | 1992-08-21 | 1998-04-01 | Genentech Inc | Procedimiento para el tratamiento de un trastorno mediado por lfa-1. |
WO1998023761A1 (en) | 1996-11-27 | 1998-06-04 | Genentech, Inc. | HUMANIZED ANTI-CD11a ANTIBODIES |
US6037454A (en) * | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
-
2000
- 2000-03-17 DK DK00916502T patent/DK1163003T3/da active
- 2000-03-17 US US09/936,603 patent/US6652855B1/en not_active Expired - Lifetime
- 2000-03-17 DE DE60042735T patent/DE60042735D1/de not_active Expired - Lifetime
- 2000-03-17 EP EP07012360A patent/EP1854480A3/de not_active Withdrawn
- 2000-03-17 IL IL14548000A patent/IL145480A0/xx unknown
- 2000-03-17 AT AT00916502T patent/ATE439145T1/de active
- 2000-03-17 JP JP2000606267A patent/JP2002540078A/ja active Pending
- 2000-03-17 CA CA002367025A patent/CA2367025A1/en not_active Abandoned
- 2000-03-17 AU AU37597/00A patent/AU764382B2/en not_active Expired
- 2000-03-17 WO PCT/US2000/007189 patent/WO2000056363A1/en active IP Right Grant
- 2000-03-17 ES ES00916502T patent/ES2331643T3/es not_active Expired - Lifetime
- 2000-03-17 EP EP00916502A patent/EP1163003B1/de not_active Expired - Lifetime
-
2001
- 2001-09-16 IL IL145480A patent/IL145480A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU3759700A (en) | 2000-10-09 |
EP1163003B1 (de) | 2009-08-12 |
US6652855B1 (en) | 2003-11-25 |
CA2367025A1 (en) | 2000-09-28 |
AU764382B2 (en) | 2003-08-14 |
DK1163003T3 (da) | 2009-11-30 |
IL145480A (en) | 2011-04-28 |
JP2002540078A (ja) | 2002-11-26 |
EP1854480A2 (de) | 2007-11-14 |
ES2331643T3 (es) | 2010-01-12 |
ATE439145T1 (de) | 2009-08-15 |
IL145480A0 (en) | 2002-06-30 |
WO2000056363A1 (en) | 2000-09-28 |
EP1854480A3 (de) | 2009-04-01 |
EP1163003A1 (de) | 2001-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0682514T3 (da) | Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma | |
GEP20002032B (en) | (54) Pyrido[2,3-d]Pyrimidines and Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Composition Comprising Them and Methods of Treatment | |
NO20051048L (no) | Terapeutisk humant anti-IL-1R1 monoklonalt antistoff | |
BR9510168A (pt) | Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição | |
GEP20043161B (en) | Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators | |
ATE216220T1 (de) | Osmotische darreichungsform mit zwei mantelschichten | |
ATE489403T1 (de) | Humane antikörper gegen cd40 | |
BRPI0417820A (pt) | heterociclos azabicìclicos como moduladores de receptor canabinóide | |
BR0312924A (pt) | Biciclo-pirazóis ativos como inibidores de quinase, processo para sua preparação e composições farmacêuticas compreendendo os mesmos | |
DE3587434D1 (de) | Antivirale pharmazeutische zusammensetzungen und ihrer verwendung. | |
HUP0300421A2 (hu) | Kezelési eljárás ligand-immunogén konjugátumok felhasználásával | |
BR0315337A (pt) | Composto, formulação farmacêutica, e, método para tratar câncer | |
DE69735634D1 (de) | Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind | |
EA200200194A1 (ru) | Антагонисты хемокинного рецептора и способы их применения | |
MXPA06000231A (es) | Derivados espiro '1-azabiciclo'2.2.2!octan-3,5'-oxazolidin-2'-ona! con afinidad a la alfa7 del receptor nicotinico para acetilcolina. | |
DK1049700T3 (da) | Kemokinreceptorantagonister og fremgangsmåder til anvendelse deraf | |
AU652778B2 (en) | Treatment composition | |
BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
BR0306732A (pt) | Tratamentos em combinação para doença alérgica compreendendo a administração de um anticorpo anti-ige e composto antialérgico | |
DE69029732D1 (de) | Bivalente metallsalze von indomethacin | |
ATE439145T1 (de) | Behandlung von lfa-1 assozieerten krankheiten durch gesteigerte dosen von lfa-1 antagonist | |
CL2004000765A1 (es) | Composicion farmaceutica intranasal que comprende un compuesto derivado de 8,9-dioxo-2,6-diazabiciclo. | |
RU94016184A (ru) | Противоаллергическая композиция для местного глазного применения, способ ее получения | |
AU7439996A (en) | Novel uses of mammalian ctla-8 and related reagents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |